Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention

Essays in Biochemistry

Volumn 46, Issue 1, 2009, Pages 111-124

  Rial, Nathaniel S ^a,b   Meyskens Jr , Frank L ^c   Gerner, Eugene W ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE;

APC PROTEIN; EFLORNITHINE; POLYAMINE; SULINDAC; WNT PROTEIN;

ANIMAL; BIOLOGICAL MODEL; CLINICAL TRIAL; GENETIC PREDISPOSITION; HUMAN; INFLAMMATION; INTESTINE TUMOR; METABOLISM; REVIEW; RISK FACTOR;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CLINICAL TRIALS AS TOPIC; EFLORNITHINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTESTINAL NEOPLASMS; MODELS, BIOLOGICAL; POLYAMINES; RISK FACTORS; SULINDAC; WNT PROTEINS;

EID: 77449134199     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSE0460008     Document Type: Article

References (30)

1. Russell, D. and Snyder, S.H. (1968) Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc. Natl. Acad. Sci. U.S.A. 60, 1420-1427
2. Fultz, K.E. and Gerner, E.W. (2002) APC-dependent regulation of ornithine decarboxylase in human colon tumor cells. Mol. Carcinog. 34, 10-18
3. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science 281, 1509- 1512
4. Bello-Fernandez, C., Packham, G. and Cleveland, J.L. (1993) The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. U.S.A. 90, 7804-7808
5. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson, M. et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589-600
6. Thun, M.J., Namboodiri, M.M. and Heath, Jr, C.W. (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325, 1593-1596
7. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. and Thun, M.J. (2007) Cancer statistics, 2007. CA Cancer J. Clin. 57, 43-66
8. Martinez, M.E., O'Brien, T.G., Fultz, K.E., Babbar, N., Yerushalmi, H., Qu, N., Guo, Y., Boorman, D., Einspahr, J., Alberts, D.S. and Gerner, E.W. (2003) Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc. Natl. Acad. Sci. U.S.A. 100, 7859-7864
9. Ignatenko, N.A., Holubec, H., Besselsen, D.G., Blohm-Mangone, K.A., Padilla-Torres, J.L., Nagle, R.B., de Alboranc, I.M., Guillen, R.J. and Gerner, E.W. (2006) Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse. Cancer Biol. Ther. 5, 1658-1664
10. Erdman, S.H., Ignatenko, N.A., Powell, M.B., Blohm-Mangone, K.A., Holubec, H., Guillen-Rodriguez, J.M. and Gerner, E.W. (1999) APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis 20, 1709-1713
11. Gerner, E.W. and Meyskens, Jr, F.L. (2004) Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 4, 781-792
12. Yerushalmi, H.F., Besselsen, D.G., Ignatenko, N.A., Blohm-Mangone, K.A., Padilla-Torres, J.L., Stringer, D.E., Guillen, J.M., Holubec, H., Payne, C.M. and Gerner, E.W. (2006) Role of polyamines in arginine-dependent colon carcinogenesis in ApcMin/+ mice. Mol. Carcinog. 45, 764-773
13. Zell, J.A., Ignatenko, N.A., Yerushalmi, H.F., Ziogas, A., Besselsen, D.G., Gerner, E.W. and Anton-Culver, H. (2007) Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Int. J. Cancer 120, 459-468
14. Uemura, T., Yerushalmi, H.F., Tsaprailis, G., Stringer, D.E., Pastorian, K.E., Hawel, III, L., Byus, C.V. and Gerner, E.W. (2008) Identification and characterization of a diamine exporter in colon epithelial cells. J. Biol. Chem. 283, 26428-26435
15. Babbar, N., Gerner, E.W. and Casero, Jr, R.A. (2006) Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem. J. 394, 317-324
16. Babbar, N., Ignatenko, N.A., Casero, Jr, R.A. and Gerner, E.W. (2003) Cyclooxygenase- independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J. Biol. Chem. 278, 47762-47775
17. Ignatenko, N.A., Besselsen, D.G., Roy, U.K., Stringer, D.E., Blohm-Mangone, K.A., Padilla-Torres, J.L., Guillen, R.J. and Gerner, E.W. (2006) Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis. Nutr. Cancer 56, 172-181
18. Coussens, L.M. and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867
19. Croghan, M.K., Aickin, M.G. and Meyskens, F.L. (1991) Dose-related α-difluoromethylornithine ototoxicity. Am. J. Clin. Oncol. 14, 331-335
20. Hixson, L.J., Garewal, H.S., McGee, D.L., Sloan, D., Fennerty, M.B., Sampliner, R.E. and Gerner, E.W. (1993) Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa. Cancer Epidemiol. Biomarkers Prev. 2, 369-374
21. Meyskens, Jr, F.L. Emerson, S.S., Pelot, D., Meshkinpour, H., Shassetz, L.R., Einspahr, J., Alberts, D.S. and Gerner, E.W. (1994) Dose de-escalation chemoprevention trial of α-difluoromethylornithine in patients with colon polyps. J. Natl. Cancer Inst. 86, 1122-1130
22. Meyskens, Jr, F.L., Gerner, E.W., Emerson, S., Pelot, D., Durbin, T., Doyle, K. and Lagerberg, W. (1998) Effect of α-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double- blinded trial for colon cancer prevention. J. Natl. Cancer Inst. 90, 1212-1218
23. Giardiello, F.M., Offerhaus, J.A., Tersmette, A.C., Hylind, L.M., Krush, A.J., Brensinger, J.D., Booker, S.V. and Hamilton, S.R. (1996) Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors. Gut 38, 578-581
24. Lawson, K.R., Ignatenko, N.A., Piazza, G.A., Cui, H. and Gerner, E.W. (2000) Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine. Cancer Epidemiol. Biomarkers Prev. 9, 1155-1162
25. Meyskens, F.L., McLaren, C.E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P.M., Hawk, E., Kelloff, G., Lawson, M.J., Kidao, J., McCracken, J. et al. (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev. Res. 1, 9-11
26. Sporn, M.B. and Hong, W.K. (2008) Clinical prevention of recurrence of colorectal adenomas by the combination of difluoromethylornithine and sulindac: an important milestone. Cancer Prev. Res. 1, 9-11
27. McClaren, C.E., Fujikawa-Brooks, S., Chen, W., Gillen, D.L., Pelot, D., Gerner, E.W. and Meyskens, F.L. (2008) Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas. Cancer Prev. Res. 1, 514-521
28. Zell, J.A., Pelot, D., Chen, W.P., McLaren, C.E., Gerner, E.W. and Meyskens, F.L. (2009) Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas. Cancer Prev. Res. 2, 209-212
29. Ignatenko, N.A., Besselsen, D.G., Stringer, D.E., Blohm-Mangone, K.A., Cui, H. and Gerner, E.W. (2008) Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis. Nutr. Cancer 60 (Suppl. 1), 30-35
30. Zoumas-Morse, C., Rock, C.L., Quintana, E.L., Neuhouser, M.L., Gerner, E.W. and Meyskens, Jr, F.L. (2007) Development of a polyamine database for assessing dietary intake. J. Am. Diet Assoc. 107, 1024-1027